GENOSS Coronary Stent Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

Also called NCT05444452

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05444452
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05444452. Randomized; no masking; primary purpose treatment. Start 2022-04-24 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GENOSS Coronary Stent Clinical Trial
Condition
Ischemic Heart Disease
Intervention (Device)
Implanatation of Genoss DES sirolimus-eluting coronary system
Intervention (Device)
Implanatation of Xience DES everolimus-eluting coronary system
Lead sponsor
Samsung Medical Center (class: other)
Collaborator
Genoss Company Limited, Suwon, Korea (class: not stated)

Record details

Record id
cardio:ct-nct05444452
Content hash
8ca7553167fe07e0acf241e43e324ae64a48f9e30673466f963e5364b10ca759